{"url":"https://etfiq.com/holdings/takeda-pharmaceutical-company-limited/","section":"holdings","title":"ETFs That Hold Takeda Pharmaceutical Company (TAK) | ETFIQ","description":"20 thematic and core ETFs hold Takeda Pharmaceutical Company Limited (TAK). PPH holds the most, at 2.81% of the fund on Nov 10, 2026.","as_of":"Nov 11, 2026","structured_data":[{"@type":"Dataset","@id":"https://etfiq.com/holdings/takeda-pharmaceutical-company-limited#data","name":"ETFs holding Takeda Pharmaceutical Company Limited","description":"Every US listed ETF that holds Takeda Pharmaceutical Company Limited, with each fund\u2019s published weight and filing date.","creator":{"@id":"https://etfiq.com/#org"},"isAccessibleForFree":true,"variableMeasured":["Share of fund","Holdings filing date"],"license":"https://etfiq.com/license/","publisher":{"@id":"https://etfiq.com/#org"},"inLanguage":"en","creativeWorkStatus":"Published","distribution":[{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/alternatives.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/core.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/crypto.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/funds.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/income.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/leverage.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/thematic.json"}]},{"@type":"FAQPage","mainEntity":[{"@type":"Question","name":"Which ETFs hold Takeda Pharmaceutical Company Limited?","acceptedAnswer":{"@type":"Answer","text":"20 thematic and core ETFs hold Takeda Pharmaceutical Company Limited, by holdings dated Jun 30, 2026 to Nov 10, 2026. The largest positions are PPH at 2.81% of the fund on Nov 10, 2026, AADR at 2.19% of the fund on Jun 30, 2026 and IFLO at 1.29% of the fund on Jun 30, 2026. 1 income and other fund on it is listed apart."}}]},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"ETFIQ","item":"https://etfiq.com/"},{"@type":"ListItem","position":2,"name":"Holdings","item":"https://etfiq.com/holdings/"},{"@type":"ListItem","position":3,"name":"Takeda Pharmaceutical Company Limited","item":"https://etfiq.com/holdings/takeda-pharmaceutical-company-limited/"}]},{"@type":"WebPage","name":"ETFs That Hold Takeda Pharmaceutical Company (TAK)","description":"20 thematic and core ETFs hold Takeda Pharmaceutical Company Limited (TAK). PPH holds the most, at 2.81% of the fund on Nov 10, 2026.","url":"https://etfiq.com/holdings/takeda-pharmaceutical-company-limited/","dateModified":"2026-11-11","isPartOf":{"@type":"WebSite","name":"ETFIQ","url":"https://etfiq.com"},"speakable":{"@type":"SpeakableSpecification","cssSelector":[".lede",".faq"]},"publisher":{"@id":"https://etfiq.com/#org"}}],"characters":4524,"truncated":false,"content":"ETFIQ / Holdings / Takeda Pharmaceutical Company Limited \n \n ETFs that hold Takeda Pharmaceutical Company Limited\n 20 thematic and core ETFs hold Takeda Pharmaceutical Company Limited , by holdings dated Jun 30, 2026 to Nov 10, 2026 . PPH holds the most, at 2.81% of the fund on Nov 10, 2026 . The next largest are AADR (2.19%) and IFLO (1.29%). \n 1 income and other fund on it is listed below.\n Thematic and core funds that hold it\n Fund Name Share of the fund Holdings filed Asset \n PPH VanEck Pharmaceutical ETF 2.81% Nov 10, 2026 Equity \n AADR AdvisorShares Dorsey Wright ADR ETF 2.19% Jun 30, 2026 Equity \n IFLO VictoryShares International Free Cash Flow ETF 1.29% Jun 30, 2026 Equity \n UIVM VictoryShares International Value Momentum ETF 0.72% Jun 30, 2026 Equity \n GINX SGI Enhanced Global Income ETF 0.72% Aug 31, 2026 Equity \n GPT Intelligent Alpha Atlas ETF 0.64% Jun 30, 2026 Equity \n DFIV Dimensional International Value ETF 0.58% Jul 31, 2026 Equity \n FVD First Trust Value Line Dividend Index Fund 0.41% Nov 10, 2026 Equity \n JSTC Adasina Social Justice All Cap Global ETF 0.35% Aug 31, 2026 Equity \n APIE ActivePassive International Equity ETF 0.26% Aug 31, 2026 Equity \n DFAI Dimensional International Core Equity Market ETF 0.19% Jul 31, 2026 Equity \n DFSI Dimensional International Sustainability Core 1 ETF 0.17% Jul 31, 2026 Equity \n SEIE SEI Select International Equity ETF 0.14% Jun 30, 2026 Equity \n DFIC Dimensional International Core Equity 2 ETF 0.12% Jul 31, 2026 Equity \n DFAX Dimensional World ex U.S. Core Equity 2 ETF 0.08% Jul 31, 2026 Equity \n DXIV Dimensional International Vector Equity ETF 0.07% Jul 31, 2026 Equity \n AVSD Avantis Responsible International Equity ETF 0.07% Nov 10, 2026 Equity \n AVDE Avantis International Equity ETF 0.06% Nov 10, 2026 Equity \n BDYN iShares Dynamic Equity Active ETF 0.06% Nov 10, 2026 Equity \n VEU Vanguard FTSE All World Ex US ETF Sep 30, 2026 Equity \n Income and other funds that hold it\n Fund Name Share of the fund Holdings filed Category \n IDVO Amplify CWP International Enhanced Dividend Income ETF 0.78% Nov 11, 2026 Income \n Funds that hold its debt\n 5 US listed ETFs hold Takeda Pharmaceutical Company Limited\u2019s debt. Only funds holding its shares are counted above.\n Fund Name Share of the fund Holdings filed Asset \n UCRD VictoryShares Corporate Bond ETF 0.26% Jun 30, 2026 Debt \n DFSB Dimensional Global Sustainability Fixed Income ETF 0.07% Jul 31, 2026 Debt \n UITB VictoryShares Core Intermediate Bond ETF 0.07% Jun 30, 2026 Debt \n DFSD Dimensional Short-Duration Fixed Income ETF 0.02% Jul 31, 2026 Debt \n DFCF Dimensional Core Fixed Income ETF Jul 31, 2026 Debt \n What this counts\n Takeda Pharmaceutical Company Limited (ticker TAK, listed in JP) is matched in every holdings book ETFIQ publishes, by its ticker and name. A share of the fund is the weight its issuer published, as of the Holdings filed date. Shares, preferred shares and debt are told by each fund\u2019s N-PORT asset type. A fund holding only the company\u2019s debt or preferred shares is listed under them, not counted as holding its shares. Options, swaps, futures and cash do not count as holding a company: a call option on a share is not the share. Funds whose book is gross exposure, not a portfolio, are left out.\n Each row shows the date the fund last filed.\n Look up another company .\n Questions people ask\n Which ETFs hold Takeda Pharmaceutical Company Limited? 20 thematic and core ETFs hold Takeda Pharmaceutical Company Limited, by holdings dated Jun 30, 2026 to Nov 10, 2026. The largest positions are PPH at 2.81% of the fund on Nov 10, 2026, AADR at 2.19% of the fund on Jun 30, 2026 and IFLO at 1.29% of the fund on Jun 30, 2026. 1 income and other fund on it is listed apart. \n Cite this page. ETFIQ, ETFs holding Takeda Pharmaceutical Company Limited, data as of Nov 12, 2026. https://etfiq.com/holdings/takeda-pharmaceutical-company-limited/ Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data .\n Other forms Plain ETFIQ, ETFs holding Takeda Pharmaceutical Company Limited, data as of Nov 12, 2026. https://etfiq.com/holdings/takeda-pharmaceutical-company-limited/ APA ETFIQ. (Nov 12, 2026). ETFs holding Takeda Pharmaceutical Company Limited. Retrieved from https://etfiq.com/holdings/takeda-pharmaceutical-company-limited/ Markdown [ETFs holding Takeda Pharmaceutical Company Limited (ETFIQ, Nov 12, 2026)](https://etfiq.com/holdings/takeda-pharmaceutical-company-limited/)","source":"ETFIQ, independent ETF data. Recomputed nightly from public filings and prices.","publisher":{"@id":"https://etfiq.com/#org","name":"ETFIQ","url":"https://etfiq.com"},"license":"https://etfiq.com/license/","license_text":"Data ETFIQ computes is free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.","citation":"ETFIQ, ETFs holding Takeda Pharmaceutical Company Limited, data as of Nov 12, 2026. https://etfiq.com/holdings/takeda-pharmaceutical-company-limited/"}